Last updated on September 2014

Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer


Brief description of study

The objective of this study is to assess efficacy and safety of radium 223 dichloride in subjects with human epidermal growth factor receptor 2 (HER2) negative hormone receptor positive breast cancer with bone metastases treated with exemestane and everolimus.

Clinical Study Identifier: NCT02258451

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Bakersfield, CA United States
  Connect »

Bayer Clinical Trials Contact

Long Beach, CA United States
  Connect »

Bayer Clinical Trials Contact

Los Angeles, CA United States
  Connect »

Bayer Clinical Trials Contact

San Francisco, CA United States
  Connect »

Bayer Clinical Trials Contact

New Haven, CT United States
  Connect »

Bayer Clinical Trials Contact

Hollywood, FL United States
  Connect »

Bayer Clinical Trials Contact

Shreveport, LA United States
  Connect »

Bayer Clinical Trials Contact

Baltimore, MD United States
  Connect »

Bayer Clinical Trials Contact

Rockville, MD United States
  Connect »

Bayer Clinical Trials Contact

Ann Arbor, MI United States
  Connect »

Bayer Clinical Trials Contact

Rochester, MN United States
  Connect »

Bayer Clinical Trials Contact

Saint Louis, MO United States
  Connect »

Bayer Clinical Trials Contact

Lake Success, NY United States
  Connect »

Bayer Clinical Trials Contact

Winston-Salem, NC United States
  Connect »

Bayer Clinical Trials Contact

Cleveland, OH United States
  Connect »

Bayer Clinical Trials Contact

Pittsburgh, PA United States
  Connect »

Bayer Clinical Trials Contact

Watertown, SD United States
  Connect »

Bayer Clinical Trials Contact

Bruxelles - Brussel, Belgium
  Connect »

Bayer Clinical Trials Contact

Vandoeuvre Les Nancy, France
  Connect »

Bayer Clinical Trials Contact

Suwon-si, Korea, Republic of
  Connect »

Bayer Clinical Trials Contact

Incheon, Korea, Republic of
  Connect »

Bayer Clinical Trials Contact

L'Hospitalet de Llobregat, Spain
  Connect »